Mortality and cancer incidence among physicians of traditional Chinese medicine: A 20-year national follow-up study

Occupational and Environmental Medicine

Volumn 67, Issue 3, 2010, Pages 166-169

  Liu, Shu Hui ^a   Liu, Yu Feng ^a   Liou, Saou Hsing ^b   Lin, Yun Lian ^c   Hsiao, Yuen Chen ^d   Chen, Chu Chieh ^e   Li, Chung Yi ^e   Wu, Trong Neng ^a,b,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^d NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANUS CANCER; ARTICLE; BILE DUCT CANCER; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHINESE MEDICINE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; INFECTION; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCUPATIONAL EXPOSURE; PHYSICIAN; PRIORITY JOURNAL; RECTUM CANCER; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; STANDARDIZED MORTALITY RATIO; TAIWAN; UTERINE CERVIX CANCER;

ADULT; CAUSE OF DEATH; COHORT STUDIES; DRUGS, CHINESE HERBAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NEOPLASMS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK FACTORS; TAIWAN; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 77949376130     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oem.2009.050021     Document Type: Article

References (12)

1. World Health Organization. WHO traditional medicine strategy 2002-2005 Geneva: WHO, 2002.
2. Ernst E. Prevalence of use of complementary alternative medicine: a systematic review. Bull World Health Organ 2000;78:252-7.
3. Liu SH, Wu CS, Lin TL, et al. Lower mortality in male physicians of Chinese medicine than male population in Taiwan. Tohoku J Exp Med 2008;216:187-94.
4. Lu TH, Chang HY, Hwu CM, et al. Comparison of official coders versus physician panel in assignment of underlying cause of death. J Formos Med Assoc 2001;100:365-9.
5. Breslow NE, Day NE. Statistical methods in cancer research. IARC Workshop 25-27 May 1983. IARC Sci Publ 1987;82:1-406.
6. Carpenter LM, Swerdlow AJ, Fear NT. Mortality of doctors in different specialties: findings from a cohort of 2000 NHS Hospital Consultants. Occup Environ Med 1997;54:388-95.
7. Lee CH, Wang JD, Chen PC. Case-crossover study of hospitalization for acute hepatitis in Chinese herb users. J Gastroenterol Hepatol 2008;23:1549-55.
8. Zhang M, Wang H, Miao J, et al. Occupational exposure to blood and body fluids among health care workers in a general hospital, China. Am J Ind Med 2009;52:89-98.
9. Yang HY, Wang JD, Lo TC, et al. Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists. J Epidemiol 2009;19:17-23.
10. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA 2004;292:2868-73.
11. Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995;55:1296-300.
12. Lai MN, Lai JN, Chen PC, et al. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology (Carlton) 2009;14:227-34.